Stock Screener
Stock Research
Market Indexes
Precious Metals
Energy
Commodities
Exchange Rates
Interest Rates
Economy
Global Metrics

Northwest Biotherapeutics Net Income 2006-2021 | NWBO

For a detailed definition, formula and example for Net Income, check out our new background page here.
Northwest Biotherapeutics net income from 2006 to 2021. Net income can be defined as company's net profit or loss after all revenues, income items, and expenses have been accounted for.
  
Northwest Biotherapeutics Annual Net Income
(Millions of US $)
2020 $-530
2019 $-21
2018 $-54
2017 $-74
2016 $-86
2015 $-115
2014 $-136
2013 $-66
2012 $-67
2011 $-33
2010 $-27
2009 $-27
2008 $-22
2007 $-58
2006 $-1
2005 $-10
Northwest Biotherapeutics Quarterly Net Income
(Millions of US $)
2021-03-31 $-4
2020-12-31 $-280
2020-09-30 $-194
2020-06-30 $-58
2020-03-31 $3
2019-12-31 $6
2019-09-30 $-6
2019-06-30 $0
2019-03-31 $-21
2018-12-31 $-6
2018-09-30 $8
2018-06-30 $-25
2018-03-31 $-32
2017-12-31 $-28
2017-09-30 $-23
2017-06-30 $-10
2017-03-31 $-13
2016-12-31 $-31
2016-09-30 $-32
2016-06-30 $-17
2016-03-31 $-6
2015-12-31 $-24
2015-09-30 $23
2015-06-30 $-67
2015-03-31 $-46
2014-12-31 $-43
2014-09-30 $-21
2014-06-30 $-26
2014-03-31 $-46
2013-12-31 $-17
2013-09-30 $-23
2013-06-30 $-12
2013-03-31 $-14
2012-12-31 $-31
2012-09-30 $-16
2012-06-30 $-10
2012-03-31 $-10
2011-12-31 $-13
2011-09-30 $0
2011-06-30 $-12
2011-03-31 $-8
2010-12-31 $-7
2010-09-30 $-5
2010-06-30 $-9
2010-03-31 $-6
2009-12-31 $-6
2009-09-30 $-12
2009-06-30 $-4
2009-03-31 $-5
2008-12-31 $-5
2008-09-30 $-5
2008-06-30 $-6
2008-03-31 $-6
2007-12-31 $-7
2007-09-30 $-4
2007-06-30 $-45
2007-03-31 $-2
2006-12-31 $-2
2006-09-30 $-2
2006-06-30 $6
2006-03-31 $-4
2005-12-31 $-2
2005-09-30 $-3
2005-06-30 $-3
2005-03-31 $-3
Sector Industry Market Cap Revenue
Medical Medical - Biomedical and Genetics $1.310B $0.001B
Northwest Biotherapeutics, Inc. is a biotechnology company focused on discovering, developing, and commercializing immunotherapy products that safely generate and enhance immune system responses to treat cancer.
Stock Name Country Market Cap PE Ratio
Bristol Myers Squibb (BMY) United States $145.715B 10.10
Amgen (AMGN) United States $137.152B 14.80
CSL (CSLLY) Australia $101.091B 0.00
Moderna (MRNA) United States $85.140B 169.63
Gilead Sciences (GILD) United States $83.591B 8.90
Illumina (ILMN) United States $68.493B 98.76
Regeneron Pharmaceuticals (REGN) United States $56.447B 16.16
Biogen (BIIB) United States $55.991B 12.81
BioNTech SE (BNTX) Germany $55.429B 40.19
Vertex Pharmaceuticals (VRTX) United States $48.542B 19.99
Alexion Pharmaceuticals (ALXN) United States $39.746B 15.10
BeiGene (BGNE) Cayman Islands $31.491B 0.00
Seagen (SGEN) United States $28.470B 49.18
Genmab (GMAB) Denmark $27.436B 32.16
Genmab (GNMSF) Denmark $26.798B 6.16
Exact Sciences (EXAS) United States $22.468B 0.00
Horizon Therapeutics Public (HZNP) Ireland $21.225B 27.14
Alnylam Pharmaceuticals (ALNY) United States $20.527B 0.00
Incyte (INCY) United States $18.722B 37.01
SINO PHARMACEUT (SBMFF) Hong Kong, SAR China $17.889B 0.00
Bio-Techne Corp (TECH) United States $17.285B 90.89
Bio-Rad Laboratories (BIO.B) United States $17.251B 41.91
ARGENX SE-ADR (ARGX) Netherlands $16.015B 0.00
Zai Lab (ZLAB) China $15.312B 0.00
BioMarin Pharmaceutical (BMRN) United States $15.091B 137.63
Novavax (NVAX) United States $14.244B 0.00
Guardant Health (GH) United States $12.907B 0.00
QIAGEN (QGEN) Netherlands $10.786B 19.15
CureVac (CVAC) Germany $10.637B 0.00
Repligen (RGEN) United States $10.592B 95.50
CRISPR Therapeutics AG (CRSP) Switzerland $9.901B 0.00
Denali Therapeutics (DNLI) United States $8.608B 308.83
Mirati Therapeutics (MRTX) United States $8.386B 0.00
Fate Therapeutics (FATE) United States $7.855B 0.00
Ascendis Pharma (ASND) Denmark $7.470B 0.00
Acceleron Pharma (XLRN) United States $7.417B 0.00
Exelixis (EXEL) United States $6.963B 111.10
Biohaven Pharmaceutical Holding (BHVN) United States $6.359B 0.00
Ultragenyx Pharmaceutical (RARE) United States $6.324B 0.00
Sarepta Therapeutics (SRPT) United States $6.251B 0.00
Halozyme Therapeutics (HALO) United States $6.141B 33.69
Vir Biotechnology (VIR) United States $6.125B 0.00
AbCellera Biologics (ABCL) $5.882B 0.00
Twist Bioscience (TWST) United States $5.874B 0.00
Adaptive Biotechnologies (ADPT) United States $5.747B 0.00
I-Mab (IMAB) China $5.719B 0.00
Intellia Therapeutics (NTLA) United States $5.697B 0.00
Legend Biotech (LEGN) United States $5.439B 0.00
Beam Therapeutics (BEAM) United States $5.389B 0.00
SWEDISH ORP BIO (BIOVF) Sweden $5.325B 19.29
NeoGenomics (NEO) United States $5.294B 897.80
Apellis Pharmaceuticals (APLS) United States $5.219B 0.00
Reata Pharmaceuticals (RETA) United States $5.117B 0.00
Blueprint Medicines (BPMC) United States $4.883B 14.86
Galapagos (GLPG) Belgium $4.535B 0.00
Arena Pharmaceuticals (ARNA) United States $4.079B 0.00
SpringWorks Therapeutics (SWTX) United States $4.076B 0.00
Certara (CERT) United States $4.034B 0.00
ACADIA Pharmaceuticals (ACAD) United States $3.928B 0.00
Alkermes (ALKS) Ireland $3.878B 0.00
Arvinas (ARVN) United States $3.721B 0.00
Intra-Cellular Therapies (ITCI) United States $3.515B 0.00
Berkeley Lights (BLI) United States $3.314B 0.00
Emergent Biosolutions (EBS) United States $3.218B 6.41
Vericel (VCEL) United States $3.003B 809.88
Insmed (INSM) United States $2.881B 0.00
Dicerna Pharmaceuticals (DRNA) United States $2.848B 0.00
BAVARIAN NORDIC (BVNRY) Denmark $2.814B 0.00
Amicus Therapeutics (FOLD) United States $2.671B 0.00
Sorrento Therapeutics (SRNE) United States $2.598B 0.00
Editas Medicine (EDIT) United States $2.565B 0.00
MorphoSys AG (MOR) Germany $2.493B 0.00
Myriad Genetics (MYGN) United States $2.433B 0.00
Heska (HSKA) United States $2.341B 1020.50
Instil Bio (TIL) United States $2.302B 0.00
Revance Therapeutics (RVNC) United States $2.239B 0.00
Global Blood Therapeutics (GBT) United States $2.222B 0.00
Bluebird Bio (BLUE) United States $2.183B 0.00
ALX Oncology Holdings (ALXO) United States $2.171B 0.00
Morphic Holding (MORF) United States $2.152B 0.00
Ligand Pharmaceuticals (LGND) United States $2.135B 35.71
Seres Therapeutics (MCRB) United States $2.132B 0.00
Prothena (PRTA) Ireland $2.125B 0.00
Deciphera Pharmaceuticals (DCPH) United States $2.079B 0.00
Bionano Genomics (BNGO) United States $2.022B 0.00
Myovant Sciences (MYOV) United Kingdom $2.007B 0.00
Kymera Therapeutics (KYMR) United States $2.006B 0.00
Seer (SEER) $1.995B 0.00
Genetron Holdings (GTH) China $1.958B 0.00
Atea Pharmaceuticals (AVIR) United States $1.917B 0.00
Protagonist Therapeutics (PTGX) United States $1.902B 0.00
Castle Biosciences (CSTL) United States $1.871B 0.00
Inovio Pharmaceuticals (INO) United States $1.820B 0.00
Amarin (AMRN) Ireland $1.792B 0.00
Harmony Biosciences Holdings (HRMY) United States $1.737B 0.00
ADC Therapeutics SA (ADCT) Switzerland $1.706B 0.00
PHARMA MAR SA (PHMMF) Spain $1.705B 0.00
Zymeworks (ZYME) Canada $1.679B 0.00
Sangamo Therapeutics (SGMO) United States $1.672B 0.00
Alector (ALEC) United States $1.664B 0.00
Arcus Biosciences (RCUS) United States $1.661B 0.00
REGENXBIO (RGNX) United States $1.637B 0.00
C4 Therapeutics (CCCC) United States $1.631B 0.00
Cytokinetics (CYTK) United States $1.600B 0.00
Immunocore Holdings (IMCR) United Kingdom $1.574B 0.00
NGM Biopharmaceuticals (NGM) United States $1.551B 0.00
Ocugen (OCGN) United States $1.499B 0.00
Y-mAbs Therapeutics (YMAB) United States $1.491B 0.00
Avid Bioservices (CDMO) United States $1.476B 0.00
PureTech Health (PRTC) United States $1.434B 0.00
OXFORD BIOMEDCL (OXBDF) United Kingdom $1.397B 0.00
UniQure (QURE) Netherlands $1.379B 0.00
Codexis (CDXS) United States $1.376B 0.00
Precigen (PGEN) United States $1.362B 0.00
BioAtla (BCAB) United States $1.321B 0.00
Nurix Therapeutics (NRIX) United States $1.306B 0.00
Zealand Pharma (ZEAL) Denmark $1.243B 0.00
MiMedx (MDXG) United States $1.238B 0.00
Forma Therapeutics Holdings (FMTX) United States $1.230B 0.00
Repare Therapeutics (RPTX) Canada $1.217B 0.00
Agenus (AGEN) United States $1.197B 0.00
Celldex Therapeutics (CLDX) United States $1.189B 0.00
Shattuck Labs (STTK) United States $1.178B 0.00
Zealand Pharma (ZLDPF) Denmark $1.135B 0.00
MannKind (MNKD) United States $1.126B 0.00
Coherus BioSciences (CHRS) United States $1.109B 0.00
Mesoblast (MESO) Australia $1.089B 0.00
KaloBios Pharmaceuticals (HGEN) United States $1.072B 0.00
Pliant Therapeutics (PLRX) United States $1.068B 0.00
Dynavax Technologies (DVAX) United States $1.060B 0.00
Vanda Pharmaceuticals (VNDA) United States $1.050B 33.16
Keros Therapeutics (KROS) United States $1.038B 0.00
Inhibrx (INBX) United States $1.011B 0.00
VBI Vaccines (VBIV) United States $0.991B 0.00
Scholar Rock Holding (SRRK) United States $0.990B 0.00
Mersana Therapeutics (MRSN) United States $0.970B 0.00
Avidity Biosciences (RNA) United States $0.948B 0.00
Cel-Sci (CVM) United States $0.938B 0.00
Epizyme (EPZM) United States $0.922B 0.00
G1 THERAPEUTICS (GTHX) United States $0.919B 0.00
Travere Therapeutics (TVTX) United States $0.899B 0.00
Arcturus Therapeutics Holdings (ARCT) United States $0.896B 0.00
Syndax Pharmaceuticals (SNDX) United States $0.871B 0.00
RAPT THERAPTICS (RAPT) United States $0.871B 0.00
Nkarta (NKTX) United States $0.870B 0.00
Sutro Biopharma (STRO) United States $0.856B 0.00
Merus (MRUS) Netherlands $0.856B 0.00
Affimed (AFMD) Germany $0.851B 0.00
Prometheus Biosciences (RXDX) United States $0.813B 0.00
Brooklyn ImmunoTherapeutics (BTX) United States $0.780B 0.00
Xenon Pharmaceuticals (XENE) Canada $0.737B 0.00
Verastem (VSTM) United States $0.732B 0.00
IDEAYA Biosciences (IDYA) United States $0.716B 0.00
SESEN BIO, INC (SESN) United States $0.714B 0.00
Pharming Group (PHAR) Netherlands $0.711B 0.00
Bicycle Therapeutics (BCYC) United Kingdom $0.708B 0.00
Cara Therapeutics (CARA) United States $0.700B 60.78
Curis (CRIS) United States $0.696B 0.00
MeiraGTx Holdings (MGTX) United States $0.690B 0.00
Intercept Pharmaceuticals (ICPT) United States $0.689B 0.00
Pharming Group (PHGUF) Netherlands $0.688B 18.33
Lexicon Pharmaceuticals (LXRX) United States $0.687B 0.00
AnaptysBio (ANAB) United States $0.682B 0.00
ALBIREO PHARMA (ALBO) United States $0.682B 0.00
Cellectis S.A (CLLS) France $0.673B 0.00
Kadmon Holdings (KDMN) United States $0.654B 0.00
Clene (CLNN) United States $0.647B 0.00
Adaptimmune Therapeutics (ADAP) United Kingdom $0.647B 0.00
Clovis Oncology (CLVS) United States $0.645B 0.00
Sinovac Biotech (SVA) China $0.642B 6.47
DBV Technologies S.A (DBVT) France $0.633B 0.00
Anika Therapeutics (ANIK) United States $0.627B 0.00
Precision BioSciences (DTIL) United States $0.615B 0.00
Adagene (ADAG) China $0.609B 0.00
ChromaDex (CDXC) United States $0.607B 0.00
Orchard Therapeutics (ORTX) United Kingdom $0.597B 0.00
AC Immune SA (ACIU) Switzerland $0.591B 0.00
ZIOPHARM Oncology Inc (ZIOP) United States $0.580B 0.00
Bolt Biotherapeutics (BOLT) United States $0.567B 0.00
Inventiva S.A (IVA) France $0.537B 0.00
Basilea Pharmaceutica AG (BPMUF) Switzerland $0.535B 0.00
Compugen (CGEN) Israel $0.532B 0.00
Selecta Biosciences (SELB) United States $0.517B 0.00
Forte Biosciences (FBRX) United States $0.498B 0.00
XBiotech (XBIT) United States $0.491B 0.00
Geron (GERN) United States $0.487B 0.00
Autolus Therapeutics (AUTL) United Kingdom $0.482B 0.00
Gritstone Bio (GRTS) United States $0.480B 0.00
Nabriva Therapeutics AG (NBRV) Ireland $0.475B 0.00
Starpharma Holdings (SPHRY) Australia $0.454B 0.00
Athenex (ATNX) United States $0.453B 0.00
Lineage Cell Therapeutics (LCTX) United States $0.452B 0.00
Codiak BioSciences (CDAK) United States $0.442B 0.00
BeyondSpring (BYSI) United States $0.437B 0.00
CytomX Therapeutics (CTMX) United States $0.434B 0.00
Spero Therapeutics (SPRO) United States $0.429B 0.00
Amryt Pharma (AMYT) United Kingdom $0.424B 0.00
Neoleukin Therapeutics (NLTX) United States $0.423B 0.00
Kindred Biosciences (KIN) United States $0.417B 0.00
AquaBounty Technologies (AQB) United States $0.412B 0.00
ANI Pharmaceuticals (ANIP) United States $0.407B 11.22
Oncobiologics (OTLK) United States $0.406B 0.00
Cue Biopharma (CUE) United States $0.403B 0.00
Angion Biomedica (ANGN) United States $0.394B 0.00
Puma Biotechnology (PBYI) United States $0.392B 0.00
Kala Pharmaceuticals (KALA) United States $0.382B 0.00
SQZ Biotechnologies (SQZ) United States $0.377B 0.00
Theratechnologies (THTX) Canada $0.366B 0.00
XOMA (XOMA) United States $0.361B 168.37
Adverum Biotechnologies (ADVM) United States $0.358B 0.00
Fortress Biotech (FBIO) United States $0.355B 0.00
ProQR Therapeutics (PRQR) Netherlands $0.354B 0.00
BioDelivery Sciences (BDSI) United States $0.353B 14.32
WAVE Life Sciences (WVE) Singapore $0.351B 0.00
UROGEN PHARMA (URGN) United States $0.350B 0.00
Cerecor (CERC) United States $0.348B 0.00
Frequency Therapeutics (FREQ) United States $0.345B 0.00
Paratek Pharmaceuticals (PRTK) United States $0.342B 0.00
Syros Pharmaceuticals (SYRS) United States $0.341B 0.00
IBio (IBIO) United States $0.340B 0.00
Opthea (OPT) Australia $0.335B 0.00
Athersys (ATHX) United States $0.329B 0.00
Aeglea BioTherapeutics (AGLE) United States $0.320B 0.00
Cogent Biosciences (COGT) United States $0.319B 0.00
Clearside Biomedical (CLSD) United States $0.310B 0.00
Trevena (TRVN) United States $0.309B 0.00
Prima BioMed (IMMP) Australia $0.309B 0.00
Arbutus Biopharma (ABUS) United States $0.307B 0.00
CorMedix Inc (CRMD) United States $0.301B 0.00
Fulcrum Therapeutics (FULC) United States $0.299B 0.00
Kaleido Biosciences (KLDO) $0.297B 0.00
Adicet Bio (ACET) United States $0.292B 0.00
OVID THERAPEUTC (OVID) United States $0.287B 2.82
Innate Pharma S.A (IPHA) France $0.284B 0.00
PDL BioPharma (PDLI) United States $0.283B 0.00
INmune Bio (INMB) United States $0.283B 0.00
Cardiff Oncology (CRDF) United States $0.277B 0.00
EYEPOINT PHARMACEUTICALS, INC (EYPT) United States $0.276B 0.00
Talis Biomedical (TLIS) United States $0.264B 0.00
Bellus Health (BLU) Canada $0.261B 0.00
Kamada (KMDA) Israel $0.256B 17.45
Chiasma (CHMA) United States $0.244B 0.00
HOOKIPA Pharma (HOOK) United States $0.243B 0.00
AVEO Pharmaceuticals (AVEO) United States $0.236B 0.00
Synlogic (SYBX) United States $0.230B 0.00
Checkpoint Therapeutics (CKPT) United States $0.226B 0.00
Pieris Pharmaceuticals (PIRS) United States $0.224B 0.00
TELA Bio (TELA) United States $0.224B 0.00
Seelos Therapeutics (SEEL) United States $0.223B 0.00
NextCure (NXTC) United States $0.218B 0.00
ADMA Biologics Inc (ADMA) United States $0.213B 0.00
VTv Therapeutics (VTVT) United States $0.204B 0.00
Galena Biopharma (SLS) United States $0.202B 0.00
POXEL SA FRANCE (PXXLF) France $0.197B 0.00
Aptinyx (APTX) United States $0.197B 0.00
Strongbridge Biopharma (SBBP) United States $0.190B 0.00
Biofrontera AG (BFRA) Germany $0.182B 0.00
F-star Therapeutics (FSTX) United Kingdom $0.179B 0.00
Applied Genetic Technologies (AGTC) United States $0.178B 0.00
OSMOTICA PHARM (OSMT) United States $0.175B 0.00
GENFIT S.A (GNFT) France $0.175B 0.00
ObsEva SA (OBSV) Switzerland $0.173B 0.00
Nicox SA (NICXF) France $0.171B 0.00
X4 Pharmaceuticals (XFOR) United States $0.169B 0.00
PHASEBIO PHARMA (PHAS) United States $0.166B 0.00
Voyager Therapeutics (VYGR) United States $0.165B 4.25
VolitionRX (VNRX) United States $0.165B 0.00
Abeona Therapeutics (ABEO) United States $0.160B 0.00
Antibe Therapeutics (ATBPF) Canada $0.154B 0.00
Entera Bio (ENTX) Israel $0.154B 0.00
Cyclerion Therapeutics (CYCN) United States $0.152B 0.00
Enzo Biochem (ENZ) United States $0.145B 42.71
Eton Pharmaceuticals (ETON) United States $0.145B 0.00
Longeveron (LGVN) United States $0.144B 0.00
Aytu BioPharma (AYTU) United States $0.142B 0.00
Eyenovia (EYEN) United States $0.140B 0.00
Liquidia Technologies (LQDA) United States $0.139B 0.00
DiaMedica Therapeutics (DMAC) United States $0.136B 0.00
ABVC BioPharma (ABVC) United States $0.133B 0.00
Beyond Air (XAIR) United States $0.133B 0.00
Exicure (XCUR) United States $0.133B 0.00
Catalyst Biosciences (CBIO) United States $0.133B 0.00
LogicBio Therapeutics (LOGC) United States $0.132B 0.00
Cocrystal Pharma (COCP) United States $0.131B 0.00
ASLAN Pharmaceuticals (ASLN) Singapore $0.130B 0.00
Novogen (KZIA) Australia $0.127B 0.00
Palatin Technologies (PTN) United States $0.126B 0.00
Pluristem Therapeutics (PSTI) Israel $0.125B 0.00
Evofem Biosciences (EVFM) United States $0.122B 0.00
Liminal BioSciences (LMNL) Canada $0.122B 0.00
Orgenesis (ORGS) United States $0.120B 245.00
ANIXA BIOSCIENCES INC (ANIX) United States $0.119B 0.00
Yumanity Therapeutics (YMTX) United States $0.118B 0.00
Erytech Pharma SA (ERYP) France $0.117B 0.00
Vyant Bio (VYNT) United States $0.116B 0.00
Vascular Biogenics (VBLT) Israel $0.112B 0.00
AEterna Zentaris (AEZS) United States $0.110B 0.00
ARAVIVE, INC (ARAV) United States $0.108B 0.00
Celsion (CLSN) United States $0.108B 0.00
Armata Pharmaceuticals (ARMP) United States $0.104B 0.00
Aptevo Therapeutics (APVO) United States $0.103B 0.00
Leap Therapeutics (LPTX) United States $0.102B 0.00
TRACON Pharmaceuticals (TCON) United States $0.102B 0.00
Zosano Pharma (ZSAN) United States $0.101B 0.00
Dyadic (DYAI) United States $0.095B 0.00
Cidara Therapeutics (CDTX) United States $0.093B 0.00
Evogene (EVGN) Israel $0.090B 0.00
Lumos Pharma (LUMO) United States $0.090B 0.00
AIkido Pharma (AIKI) United States $0.090B 0.00
Stealth BioTherapeutics (MITO) Cayman Islands $0.085B 0.00
Protalix BioTherapeutics (PLX) Israel $0.084B 0.00
Aerpio Pharmaceuticals (ARPO) United States $0.082B 0.00
Vaccinex (VCNX) United States $0.081B 0.00
Purple Biotech (PPBT) Israel $0.081B 0.00
Cleveland BioLabs (CBLI) United States $0.080B 0.00
ARIDIS PHARMACT (ARDS) United States $0.079B 0.00
Emmaus Life Sciences (EMMA) United States $0.078B 0.00
Adocia (ADOCY) France $0.077B 0.00
BioCardia (BCDA) United States $0.077B 0.00
Celyad SA (CYAD) Belgium $0.075B 0.00
ATyr Pharma (LIFE) United States $0.073B 0.00
Edesa Biotech (EDSA) Canada $0.072B 0.00
Advaxis (ADXS) United States $0.071B 0.00
Idera Pharmaceuticals (IDRA) United States $0.069B 0.00
Viridian Therapeutics (VRDN) United States $0.068B 0.00
Cyclo Therapeutics (CYTH) United States $0.068B 0.00
Alimera Sciences (ALIM) United States $0.063B 0.00
Genetic Technologies (GENE) Australia $0.061B 0.00
Organovo Holdings (ONVO) United States $0.060B 0.00
Cyclacel Pharmaceuticals (CYCC) United States $0.060B 0.00
Windtree Therapeutics (WINT) United States $0.059B 0.00
Pulmatrix (PULM) United States $0.057B 0.00
AnPac Bio-Medical Science (ANPC) China $0.048B 0.00
Soligenix (SNGX) United States $0.047B 0.00
Invo BioScience (INVO) United States $0.047B 0.00
Enveric Biosciences (ENVB) United States $0.047B 0.00
Acorda Therapeutics (ACOR) United States $0.046B 1.12
Timber Pharmaceuticals (TMBR) United States $0.043B 0.00
Happiness Biotech Group (HAPP) China $0.042B 0.00
Vallon Pharmaceuticals (VLON) United States $0.036B 0.00
Lexaria Bioscience (LEXX) Canada $0.034B 0.00
Benitec Biopharma (BNTC) United States $0.034B 0.00
Sonnet BioTherapeutics Holdings (SONN) United States $0.033B 0.00
PLANET GREEN HOLDINGS CORP (PLAG) China $0.033B 0.00
GeoVax Labs (GOVX) United States $0.032B 0.00
ThermoGenesis Holdings (THMO) United States $0.032B 0.00
Prana Biotechnology (ATHE) Australia $0.030B 0.00
IMMURON (IMRN) Australia $0.028B 0.00
Titan Pharmaceuticals (TTNP) United States $0.026B 0.00
ZIVO Bioscience (ZIVO) United States $0.024B 0.00
Palisade Bio (PALI) United States $0.012B 0.00
CollPlant Biotechnologies (CLGN) Israel $0.000B 0.00
ImmunityBio (IBRX) United States $0.000B 0.00
Immatics (IMTX) United States $0.000B 0.00